Is KBGCF or MRK a better dividend investment in 2026?

KBGCF currently yields 1481.48% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: KBGCF offers higher current income.

What is the dividend yield difference between KBGCF and MRK?

KBGCF has a forward dividend yield of 1481.48% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 1478.72 percentage points.

Home › Compare › KBGCF vs MRK

KBGCF vs MRK: Dividend Comparison 2026

KBGCF yields 1481.48% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KBGCF wins by $626785561.40M in total portfolio value

INVESTMENT

TIME HORIZON10 years

KBGCF

● Live price

1481.48%

Share price

$0.14

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$626785561.46M

Annual income

$553,314,905,198,340.25

Full KBGCF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — KBGCF vs MRK

📍 KBGCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KBGCF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KBGCF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KBGCF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBGCF

Annual income on $10K today (after 15% tax)

$125,925.93/yr

After 10yr DRIP, annual income (after tax)

$470,317,669,418,589.20/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, KBGCF beats the other by $470,317,669,410,260.75/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBGCF + MRK for your $10,000?

KBGCF: 50%MRK: 50%

100% MRK50/50100% KBGCF

Portfolio after 10yr

$313392780.76M

Annual income

$276,657,452,604,069.20/yr

Blended yield

88.28%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KBGCF

No analyst data

Altman Z

-46.4

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBGCF buys

MRK buys

No recent congressional trades found for KBGCF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKBGCFMRK

Forward yield	1481.48% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$626785561.46M ✓	$56.8K
Annual income after 10y	$553,314,905,198,340.25 ✓	$9,798.13
Total dividends collected	$621430185.90M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: KBGCF vs MRK ($10,000, DRIP)

Year	KBGCF Portfolio	KBGCF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$158,848	$148,148.15	$11,206	$366.19	+$147.6K → KBGCF
2	$2,369,319	$2,199,351.31	$12,650	$502.35	+$2.36M → KBGCF
3	$33,193,761	$30,658,589.95	$14,407	$694.19	+$33.18M → KBGCF
4	$436,939,498	$401,422,173.47	$16,585	$967.82	+$436.92M → KBGCF
5	$5,405,881,572	$4,938,356,308.99	$19,342	$1,363.89	+$5405.86M → KBGCF
6	$62,885,313,260	$57,101,019,978.27	$22,913	$1,947.19	+$62885.29M → KBGCF
7	$688,074,536,789	$620,787,251,600.62	$27,662	$2,823.89	+$688074.51M → KBGCF
8	$7,084,361,831,143	$6,348,122,076,778.87	$34,159	$4,173.35	+$7084361.80M → KBGCF
9	$68,664,164,726,111	$61,083,897,566,788.09	$43,337	$6,308.80	+$68664164.68M → KBGCF
10	$626,785,561,455,279	$553,314,905,198,340.25	$56,776	$9,798.13	+$626785561.40M → KBGCF

KBGCF vs MRK: Complete Analysis 2026

KBGCF — Stock

Lion Rock Resources Inc. engages in acquiring, exploring, developing, and evaluating mineral resource properties in Canada. It focuses on the Maybrun property, a gold-copper project located approximately 80 km southeast of Kenora, Ontario. The company was formerly known as King's Bay Resources Corp. and changed its name to Lion Rock Resources Inc. in July 2022. Lion Rock Resources Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada.

Full KBGCF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this KBGCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBGCF vs SCHD KBGCF vs JEPI KBGCF vs O KBGCF vs KO KBGCF vs MAIN KBGCF vs JNJ KBGCF vs ABBV KBGCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.